Low Serum 25-Hydroxyvitamin D Levels Are Associated With Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study

Low Serum 25-Hydroxyvitamin D Levels Are Associated With Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study

BackgroundIncreasing evidence suggests a link between vitamin D and polycystic ovary syndrome (PCOS). However, whether vitamin D is related to hyperandrogenemia in PCOS is still inconclusive. The aim of our study is to elucidate the relationship between vitamin D and hyperandrogenemia in women with...

Full description

Bibliographic Details
Main Authors:	Chang Shan, Yu-chen Zhu, Jie Yu, Yi Zhang, Yu-ying Wang, Nan Lu, Jie Cai, Wei Liu, Tao Tao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Endocrinology
Subjects:	vitamin D deficiency 25(OH)D polycystic ovary syndrome hyperandrogenemia overweight
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.894935/full

Similar Items

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
by: Mardia López-Alarcón, et al.
Published: (2023-08-01)

Vitamin D Concentrations at Term Do Not Differ in Newborns and Their Mothers with and without Polycystic Ovary Syndrome
by: Martina Kollmann, et al.
Published: (2021-02-01)

Vascular abnormalities and low-grade chronic inflammation in women with polycystic ovary syndrome: Relationships with insulin resistance, obesity and hyperandrogenemia
by: Ilie Ioana, et al.
Published: (2008-09-01)

Anti-Müllerian hormone as a diagnostic marker in Egyptian infertile polycystic ovary syndrome females: Correlations with Vitamin D, total testosterone, dyslipidemia and anthropometric parameters
by: Bakeer Engy, et al.
Published: (2018-01-01)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
by: Ozlem Kara, et al.
Published: (2023-09-01)

Body Fat Distribution in Thai Reproductive-Aged Polycystic Ovary Syndrome Women Compared with Non-Polycystic Ovary Syndrome Women
by: Thanyarat Wongwananuruk, et al.
Published: (2024-02-01)

Association of Maternal Serum 25-Hydroxyvitamin D Concentrations with Risk of Gestational Anemia
by: Yingdi Yuan, et al.
Published: (2017-10-01)

Comparison of 25-hydroxyvitamin D and Calcium Levels between Polycystic Ovarian Syndrome and Normal Women
by: Ashraf Moini, et al.
Published: (2015-04-01)

Association of FTO gene variant rs9939609 with hyperandrogenemia and fasting glucose levels in South Indian women with polycystic ovarian syndrome
by: Zeinab Naghshband, et al.
Published: (2022-04-01)

Concentration levels of serum 25-Hydroxyvitamin-D and vitamin D deficiency among children and adolescents of India: a descriptive cross-sectional study
by: Akif Mustafa, et al.
Published: (2021-08-01)

The relationship of serum 25-dihydroxy vitamin D3 concentrations with metabolic parameters in non-obese women with polycystic ovarian syndrome
by: Homeira Rashidi, et al.
Published: (2016-12-01)

Quercetin and polycystic ovary syndrome
by: Congshun Ma, et al.
Published: (2022-12-01)

Assessment of Vitamin D Status in Slovenian Premenopausal and Postmenopausal Women, Using Total, Free, and Bioavailable 25-Hydroxyvitamin D (25(OH)D)
by: Vid Vičič, et al.
Published: (2022-12-01)

Low Vitamin D Level in Saudi Women With Polycystic Ovary Syndrome
by: Iman Abdullah Bindayel
Published: (2021-04-01)

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome
by: Hongying Shan, et al.
Published: (2022-07-01)

Longitudinal Vitamin D Deficiency Among Malaysian Pregnant Women and Its Correlation With Neonatal Serum 25-Hydroxyvitamin D Levels
by: Muzaitul Akma Mustapa Kamal Basha, et al.
Published: (2021-06-01)

25-hydroxyvitamin D (25-OHD) levels in Turkish geriatric population: A nationwide study
by: Çağlayan Murat, et al.
Published: (2022-01-01)

Association between serum 25-hydroxyvitamin D and osteoarthritis: A national population-based analysis of NHANES 2001–2018
by: Guoyu Yu, et al.
Published: (2023-02-01)

Polycystic ovary syndrome and 25-hydroxyvitamin D: A bidirectional two-sample Mendelian randomization study
by: Nana Zhang, et al.
Published: (2023-03-01)

Implications of standardization of serum 25-hydroxyvitamin D data for the evaluation of vitamin D status in Germany, including a temporal analysis
by: Martina Rabenberg, et al.
Published: (2018-07-01)

Effects of Vitamin D on Fertility, Pregnancy and Polycystic Ovary Syndrome—A Review
by: Szabolcs Várbíró, et al.
Published: (2022-04-01)

Persistent Increase in Serum 25-Hydroxyvitamin D Concentration in a Dog Following Cholecalciferol Intoxication
by: Charlotte Gerhard, et al.
Published: (2020-01-01)

Vitamin D status among adolescent females with polycystic ovary syndrome
by: V.I. Pankiv, et al.
Published: (2022-09-01)

Potential benefits of adlay on hyperandrogenism in human chorionic gonadotropin-treated theca cells and a rodent model of polycystic ovary syndrome
by: Chi-Hao Wu, et al.
Published: (2014-11-01)

Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment
by: Xing C, et al.
Published: (2022-02-01)

Vitamin D status, frequency of its insufficiency and deficiency in women with polycystic ovary syndrome
by: I.V. Pankiv, et al.
Published: (2018-09-01)

Serum 25‐hydroxyvitamin D concentration and infectious respiratory disease complex in shelter dogs
by: Jared A. Jaffey, et al.
Published: (2021-01-01)

Effects of intestinal flora on polycystic ovary syndrome
by: Jiayue Liu, et al.
Published: (2023-03-01)

Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients
by: Shi W, et al.
Published: (2021-10-01)

Cardiometabolic Risk Factors and Its Association with Hyperandrogenemia Among Sudanese Reproductive Women with Polycystic Ovary Syndrome
by: Abdelgadir Elmugadam, et al.
Published: (2023-12-01)

Adrenal myelolipoma with hyperandrogenemia and schizophrenia
by: Liu N, et al.
Published: (2018-02-01)

Serum 25‐hydroxyvitamin D concentrations in dogs with coccidioidomycosis and variables associated with extent of clinically evident disease
by: Jared A. Jaffey, et al.
Published: (2023-01-01)

25 Hydroxyvitamin D Serum Concentration and COVID-19 Severity and Outcome—A Retrospective Survey in a Romanian Hospital
by: Adriana Topan, et al.
Published: (2023-02-01)

Assessment of Serum Vitamin D Levels in Women with Polycystic Ovary Syndrome
by: Rana A. Hamdi, et al.
Published: (2018-09-01)

The effect of correction of serum level of vitamin D on hyperandrogenism in women with polycystic ovary syndrome and hypovitaminosis D
by: A. M. Maysara, et al.
Published: (2020-04-01)

The impact of obesity on hyperandrogenemia in Korean girls
by: Min Jae Kang, et al.
Published: (2016-12-01)

A study on the relation of attention deficit/hyperactivity disorder symptoms with obesity in women with polycystic ovary syndrome
by: Hüda Murat Soyak, et al.
Published: (2023-12-01)

Distribution and Determinants of Vitamin D-Binding Protein, Total, “Non-Bioavailable”, Bioavailable, and Free 25-Hydroxyvitamin D Concentrations among Older Adults
by: Anna Zhu, et al.
Published: (2021-11-01)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
by: Chuan Xing, et al.
Published: (2022-08-01)

25-Hydroxyvitamin D Serum Levels Linked to Single Nucleotide Polymorphisms (SNPs) (rs2228570, rs2282679, rs10741657) in Skeletal Muscle Aging in Institutionalized Elderly Men Not Supplemented with Vitamin D
by: Diego Fernández-Lázaro, et al.
Published: (2022-10-01)